Protagenic Therapeutics Q4 EPS $(0.38) Down From $(0.14) YoY
Portfolio Pulse from Benzinga Newsdesk
Protagenic Therapeutics (NASDAQ:PTIX) reported a significant increase in its quarterly losses to $(0.38) per share, a 171.43% decrease from $(0.14) per share in the same period last year.
April 02, 2024 | 12:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Protagenic Therapeutics reported a substantial increase in its quarterly losses, indicating a negative performance compared to the same period last year.
The reported increase in losses for Protagenic Therapeutics is a clear indicator of negative performance, which is likely to impact investor sentiment and potentially lead to a decrease in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100